Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bone lesions in Langerhans cell histiocytosis.
Fiorillo A, Sadile F, De Chiara C, Parasole R, Simeone D, D'Amore R, D'Alvano L, Cigala F. Fiorillo A, et al. Among authors: parasole r. Clin Pediatr (Phila). 1993 Feb;32(2):118-20. doi: 10.1177/000992289303200213. Clin Pediatr (Phila). 1993. PMID: 8432075 No abstract available.
Sirolimus as maintenance treatment in an infant with life-threatening multiresistant pure red cell anemia/autoimmune hemolytic anemia.
Miano M, Poggi V, Banov L, Fioredda F, Micalizzi C, Svahn J, Montobbio G, Gallicola F, Molinari AC, Parasole R, Petruzziello F, Fischer A, Calvillo M, Dufour C. Miano M, et al. Among authors: parasole r. J Pediatr Hematol Oncol. 2014 Apr;36(3):e145-8. doi: 10.1097/MPH.0b013e31828d9928. J Pediatr Hematol Oncol. 2014. PMID: 23588343
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study.
Conter V, Valsecchi MG, Parasole R, Putti MC, Locatelli F, Barisone E, Lo Nigro L, Santoro N, Aricò M, Ziino O, Pession A, Testi AM, Micalizzi C, Casale F, Zecca M, Casazza G, Tamaro P, La Barba G, Notarangelo LD, Silvestri D, Colombini A, Rizzari C, Biondi A, Masera G, Basso G. Conter V, et al. Among authors: parasole r. Blood. 2014 Mar 6;123(10):1470-8. doi: 10.1182/blood-2013-10-532598. Epub 2014 Jan 10. Blood. 2014. PMID: 24415536 Free article. Clinical Trial.
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol.
Franca R, Rebora P, Bertorello N, Fagioli F, Conter V, Biondi A, Colombini A, Micalizzi C, Zecca M, Parasole R, Petruzziello F, Basso G, Putti MC, Locatelli F, d'Adamo P, Valsecchi MG, Decorti G, Rabusin M. Franca R, et al. Among authors: parasole r. Pharmacogenomics J. 2017 Jan;17(1):4-10. doi: 10.1038/tpj.2015.83. Epub 2015 Dec 8. Pharmacogenomics J. 2017. PMID: 26644204 Free article.
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
Conter V, Valsecchi MG, Buldini B, Parasole R, Locatelli F, Colombini A, Rizzari C, Putti MC, Barisone E, Lo Nigro L, Santoro N, Ziino O, Pession A, Testi AM, Micalizzi C, Casale F, Pierani P, Cesaro S, Cellini M, Silvestri D, Cazzaniga G, Biondi A, Basso G. Conter V, et al. Among authors: parasole r. Lancet Haematol. 2016 Feb;3(2):e80-6. doi: 10.1016/S2352-3026(15)00254-9. Epub 2016 Jan 26. Lancet Haematol. 2016. PMID: 26853647
Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL.
Locatelli F, Valsecchi MG, Möricke A, Zimmermann M, Gruhn B, Biondi A, Kulozik AE, Silvestri D, Bodmer N, Putti MC, Burdach S, Micalizzi C, Teigler-Schlegel A, Ritter J, Pession A, Cario G, Bielack S, Basso G, Klingebiel T, Vinti L, Rizzari C, Attarbaschi A, Santoro N, Parasole R, Mann G, Karawajew L, Haas OA, Conter V, Schrappe M. Locatelli F, et al. Among authors: parasole r. Blood. 2017 Nov 9;130(19):2146-2149. doi: 10.1182/blood-2017-05-782086. Epub 2017 Sep 22. Blood. 2017. PMID: 28939722 Free article. Clinical Trial. No abstract available.
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study.
Testi AM, Attarbaschi A, Valsecchi MG, Möricke A, Cario G, Niggli F, Silvestri D, Bader P, Kuhlen M, Parasole R, Putti MC, Lang P, Flotho C, Mann G, Rizzari C, Barisone E, Locatelli F, Linderkamp C, Lauten M, Suttorp M, Zimmermann M, Basso G, Biondi A, Conter V, Schrappe M; AIEOP-BFM (Associazione Italiana di Ematologia e Oncologia Pediatrica & Berlin-Frankfurt-Münster) Study Group. Testi AM, et al. Among authors: parasole r. Eur J Cancer. 2019 Nov;122:61-71. doi: 10.1016/j.ejca.2019.09.004. Epub 2019 Oct 17. Eur J Cancer. 2019. PMID: 31629941
Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma.
Vinti L, Pagliara D, Buffardi S, Di Ruscio V, Stocchi F, Mariggiò E, Parasole R, Di Matteo A, Petruzziello F, Paganelli V, De Vito R, Del Bufalo F, Strocchio L, Locatelli F. Vinti L, et al. Among authors: parasole r. Pediatr Blood Cancer. 2022 Apr;69(4):e29557. doi: 10.1002/pbc.29557. Epub 2022 Feb 2. Pediatr Blood Cancer. 2022. PMID: 35107876
64 results